It is estimated that in 2023, cellular and gene therapies will total between 70 per million members and 43 per million members compared with just 7 per million members 9 in 2020. 50-100 87% gene and cell therapies are anticipated of employers are concerned 1 to receive FDA approval by 2025. about the new million- dollar treatments getting approved by the FDA.9 2023 Benefits Trends: The evolving workplace 67